Royal Caribbean heads into its July 28 earnings with a 11% weekly price drop, a fresh analyst initiation well above the current price, and short sellers who have spent six weeks unwinding positions.
The most striking data point this week is not the selloff — it is the analyst activity running directly against it. BMO Capital initiated coverage on July 8 with an Outperform rating and a $370 target, roughly 31% above Tuesday's close of $282.26. That follows Citigroup raising its target to $362 in mid-June and Wells Fargo nudging its Overweight target to $361 a week later. The direction of the Street is unmistakable: 15 buy ratings, no sells in the consensus, with mean targets clustered in the $340–$370 range. The outlier is Morgan Stanley, which held its Equal-Weight in late May and trimmed its target to $280 — almost exactly where the stock is trading now — suggesting at least one desk sees limited near-term upside even after the pullback.
Short positioning tells a story of retreat, not escalation. Short interest has fallen roughly 19% over the past month to 4.1% of free float, with the bulk of that covering happening in the back half of June. The borrow market is relaxed: cost to borrow is running at 0.45%, its lowest level in the 30-day window, and availability is extremely loose at over 1,000% — meaning there are far more shares available to lend than are currently borrowed. This is the opposite of a squeezed setup. Shorts are leaving, not piling in, and there is ample room for new positions in either direction.
Options positioning adds a mild note of caution. The put/call ratio is running at 1.31, modestly above its 20-day average of 1.27, though the z-score of just 0.23 means this is nowhere near alarming. One date worth flagging: on June 30 the PCR spiked to 2.08 — the 52-week high — before rapidly reverting. That outlier spike has since faded, and the current reading is simply in line with the recent range. Overall, options traders are not making an aggressive directional call.
Valuation context reinforces why the selloff matters. The trailing P/E has compressed to 16.4x and EV/EBITDA is at 12.9x, both drifting lower over the past week as the stock falls faster than estimates move. On factor scores, the EPS surprise rank at 69 and 30-day EPS momentum at 64 are constructive, but forward earnings growth (ranked 25th percentile) remains a pressure point — the bear case that consensus top-line estimates are being revised down slowly. The dividend score of 98 is a curiosity: the last dividend in the data dates to early 2020, so that reading likely reflects the yield-on-historical-payment calculation rather than an active payout programme.
The stock fell harder than close peers this week. CCL dropped 8.6% and NCLH fell 14.1%, suggesting sector-wide pressure rather than RCL-specific news. VIK shed only 4.7%, holding up noticeably better. With Q2 results due July 28, the next three weeks are about whether the booking commentary can close the gap between where the stock is trading and where the Street thinks it should be.
See the live data behind this article on ORTEX.
Open RCL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
